scholarly journals Correction to: Plerixafor for mobilization and collection of haematopoietic stem cells for autologous transplantation in Japanese patients with non-Hodgkin lymphoma: a randomized phase 2 study

2018 ◽  
Vol 108 (5) ◽  
pp. 564-564
Author(s):  
Kosei Matsue ◽  
Kyoya Kumagai ◽  
Isamu Sugiura ◽  
Takayuki Ishikawa ◽  
Tadahiko Igarashi ◽  
...  
Keyword(s):  
Stem Cells ◽  
Hodgkin Lymphoma ◽  
Autologous Transplantation ◽  
Japanese Patients ◽  
Phase 2 ◽  
Haematopoietic Stem Cells ◽  
Non Hodgkin Lymphoma ◽  
Phase 2 Study ◽  
Randomized Phase 2

scholarly journals Primary Analysis of ZUMA-5: A Phase 2 Study of Axicabtagene Ciloleucel (Axi-Cel) in Patients (Pts) with Relapsed/Refractory (R/R) Indolent Non-Hodgkin Lymphoma (iNHL)

2021 ◽  
Vol 27 (3) ◽  
pp. S67-S68
Author(s):  
Caron A. Jacobson ◽  
Julio C. Chavez ◽  
Alison R. Sehgal ◽  
Basem M. William ◽  
Javier Munoz ◽  
...  
Keyword(s):  
Hodgkin Lymphoma ◽  
Phase 2 ◽  
Primary Analysis ◽  
Non Hodgkin Lymphoma ◽  
Phase 2 Study

Patient-reported outcomes data from a phase 2 study of idelalisib in patients with refractory indolent B-cell non-Hodgkin lymphoma (iNHL).

2014 ◽  
Vol 32 (15_suppl) ◽  
pp. e19554-e19554 ◽  
Author(s):  
Nina D. Wagner-Johnston ◽  
Ajay K. Gopal ◽  
Brad S. Kahl ◽  
Sven De Vos ◽  
Stephen J. Schuster ◽  
...  
Keyword(s):  
B Cell ◽  
Hodgkin Lymphoma ◽  
Patient Reported Outcomes ◽  
Phase 2 ◽  
Non Hodgkin Lymphoma ◽  
Phase 2 Study ◽  
Patient Reported

scholarly journals A phase 2 study of weekly temsirolimus and bortezomib for relapsed or refractory B-cell non-Hodgkin lymphoma: A Wisconsin Oncology Network study

Cancer ◽  
2015 ◽  
Vol 121 (19) ◽  
pp. 3465-3471 ◽  
Author(s):  
Timothy S. Fenske ◽  
Namrata M. Shah ◽  
Kyung Mann Kim ◽  
Sandeep Saha ◽  
Chong Zhang ◽  
...  
Keyword(s):  
B Cell ◽  
Hodgkin Lymphoma ◽  
Phase 2 ◽  
Non Hodgkin Lymphoma ◽  
Phase 2 Study

The dual SYK/JAK inhibitor cerdulatinib demonstrates rapid tumor responses in a phase 2 study in patients with relapsed/refractory B- and T-cell non-Hodgkin lymphoma (NHL).

2018 ◽  
Vol 36 (15_suppl) ◽  
pp. 7511-7511 ◽  
Author(s):  
Paul A. Hamlin ◽  
Bruce D. Cheson ◽  
Charles Michael Farber ◽  
Tatyana Feldman ◽  
Timothy S Fenske ◽  
...  
Keyword(s):  
T Cell ◽  
Hodgkin Lymphoma ◽  
Jak Inhibitor ◽  
Phase 2 ◽  
Non Hodgkin Lymphoma ◽  
Phase 2 Study

scholarly journals Phase 2 study of intrathecal, long-acting liposomal cytarabine in the prophylaxis of lymphomatous meningitis in human immunodeficiency virus-related non-Hodgkin lymphoma

Cancer ◽  
2010 ◽  
Vol 116 (6) ◽  
pp. 1495-1501 ◽  
Author(s):  
Michele Spina ◽  
Emanuela Chimienti ◽  
Ferdinando Martellotta ◽  
Emanuela Vaccher ◽  
Massimiliano Berretta ◽  
...  
Keyword(s):  
Human Immunodeficiency Virus ◽  
Hodgkin Lymphoma ◽  
Liposomal Cytarabine ◽  
Phase 2 ◽  
Lymphomatous Meningitis ◽  
Non Hodgkin Lymphoma ◽  
Phase 2 Study ◽  
Immunodeficiency Virus ◽  
Long Acting
Sign in / Sign up

Export Citation Format

Share Document